A significant number of men undergoing cancer treatment face sexual health challenges, yet the vast majority suffer in silence. According to a recent press release, about 90% of men treated for prostate cancer and nearly 50% of men treated for other types of cancer experience some degree of sexual dysfunction or erectile difficulties. Despite the prevalence, most men never discuss these issues with their healthcare providers, missing out on potential solutions that could improve their quality of life.
The press release emphasizes that this suffering need not continue, as there are many ways to address sexual challenges for men with cancer. It points to ongoing research and development in cancer treatments with fewer side effects, such as those by Calidi Biotherapeutics Inc. (NYSE American: CLDI), which offer hope for better outcomes. However, for current patients, the message is clear: help is available, and patients are encouraged to speak openly with their doctors.
The impact of untreated sexual dysfunction extends beyond physical health, affecting mental well-being, relationships, and overall quality of life. For cancer survivors, addressing these issues can be a crucial part of the recovery journey. The press release, distributed by BioMedWire, a communications platform focused on biotechnology and life sciences, aims to raise awareness about this often-overlooked aspect of cancer care.
BioMedWire is part of the Dynamic Brand Portfolio @IBN, which provides services including access to a network of wire solutions, article syndication to over 5,000 outlets, and social media distribution. The platform is designed to help private and public companies reach investors, influencers, and the general public. For more information, visit the BioMedWire website and review the disclaimers.
This news matters because it highlights a critical gap in cancer care: the emotional and sexual health of patients. By breaking the silence, patients can access treatments and support that can significantly improve their post-treatment lives. For the healthcare industry, it underscores the need for holistic care approaches that address both the disease and its side effects. For readers, it serves as a reminder that seeking help for sexual dysfunction after cancer is not only normal but essential for full recovery.
